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doi:10.1016/j.jfma.2010.11.001Background/Purpose: Otologic and audiologic characteristics of Turner syndrome (TS) have
been well documented in Caucasiandbut not in Asiandpopulations. We report these features
and possible causative factors for hearing loss in ethnic Chinese TS patients in Taiwan.
Methods: The study was a cross-sectional trial that analyzed patients diagnosed with TS. We
enrolled patients for otologic evaluations and age-appropriate pure tone audiometry. To
explore the potential associations with hearing loss, we studied patient karyotype, history
of recurrent otitis media (OM) and various craniofacial anomalies.
Results: The 46 patients (mean age 17.3 years, range 5e34 years) enrolled, 22 (47.8%) had
a history of recurrent OM. Otoscopic examination identified eardrum abnormalities in 45.6%
of patients with myringosclerosis as the most common condition. A total of 21.7% patients
showed auricular anomalies. Audiologic analysis revealed five cases (10.7%) with conductive
hearing loss (CHL) and eight cases (17.4%) with sensorineural hearing loss (SNHL). Among
patients with a history of recurrent OM, CHL prevailed (p Z 0.0192) over SNHL (p Z 0.1278).
Karyotype and craniofacial anomalies were not associated with CHL or SNHL (p > 0.05).
Conclusion: We found varying degrees of otologic and audiologic abnormalities among the TS in
ethnic Chinese population. About one-half of the patients had recurrent OM, which was more
likely to be associated with CHL in early life. Therefore, regular surveillance, early diagnosis,ediatric Endocrinology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5,
3, Taiwan.
.org.tw (F.-S. Lo).
ight ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
Otologic-audiologic features of Turner syndrome 95Table 1 Profiles of audiologic fe
Author (year) Case
numb
Sculerati et al2 (1990) 22
Hultcrantz et al3 (1994) 44
Sculerati et al4 (1996) 24
Hultcrantz and Sylven5
(1997)
40
Benazzo et al6 (1997) 62
Stenberg et al7 (1998) 56
Barrenas et al8 (1999) 115
Arrenas et al9 (2000) 119
Gungor et al10 (2000) 38
Serra et al11 (2003) 21
Hultcrantz et al12 (2003) 325
Beckman et al13 (2004) 113
Ostberg et al14 (2004) 138
Dhooge et al15 (2005) 41
Morimoto et al16 (2006) 33
King et al17 (2007) 200
Bergamachi et al18
(2008)
173
Gawron et al19 (2008) 51
Parkin et al20 (2009) 23
Makishima et al21 (2009) 91
Chan et al (current study) 46
CHL Z conductive hearing loss; HFS
SNHL Z sensorineural hearing loss.and the initiation of appropriate treatment are crucial in improving the hearing and speech in
children with TS as well as in preventing short- and long-term associated complications.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Tuner syndrome (TS) is one of the most frequently
encountered sex chromosomal abnormalities, occurring in
one per 20,000 female births.1 Total or partial loss of one
sex chromosome in all or some cells causes TS. These
patients present with short stature, ovarian insufficiency
due to ovarian dysgenesis, failure to enter puberty
spontaneously, and infertility. Other TS-associated abnor-
malities include webbing of the neck, high-arched palate,
low-set ears, micrognathia, low posterior hairline, cubitus
valgus, coarctation of the aorta, horseshoe kidney, and
autoimmune diseases.
Previous studies have reported an increased incidence
of otitis media (OM) and hearing loss among TS patientsatures in Turner syndrome in t
er
Age (yr) Recurrent
OM (%)
CHL
(%)
1e40 82 36/
36e67 52 0/1
3e62 88 6
16e34 68 0/8
5e32 48 26
4e15 61 44
4e60 68 26
4e73 70 26
3e38 68 11/
6e25 19 43/
4e68 61 d
15e52 33 19
16e67 56 19
Median
age (24)
66 21
8e40 12 24
7e61 d 9/3
3e24 d 38.7
2e30 20 12/
1e16 91 d
7e61 76 d
4e33 48 10.7
NHL Z high-frequency sensorineu(Table 1).2e20 The reported incidence of recurrent OM varies
from 12% to 91%,16,20 although the exact cause remains
unknown. According to a large-scale population study (200
cases), approximately 50% of TS patients suffer from hearing
loss with conductive, sensorineural, or mixed pattern.17 The
common reasons for conductive hearing loss (CHL) in TS
patients are recurrent OM with effusion, chronic OM, cho-
lesteatoma formation (likely as the result of failure of the
Eustachian tube associated with lymphedema4), and the
actual anatomic shortening of the skull base or congenital
craniofacial abnormalities.18 Several case studies suggest
that monosomy 45,X8,14,18 or isochromosome 46,i(Xq)8 is
significantly associated with CHL in TS patients.
Sensorineural hearing loss (SNHL) associates with the
deletion of the short arm of the X chromosome9,12 andhe last 20 years.
/MHL SNHL
(%)
Country Factors affecting HL
23 14 USA d
2 78 Sweden d
50 USA No relation with parental origin of
X chromosome karyotype
45 Sweden d
21 Italy d
14 Sweden d
17 Sweden Degree of deletion of the p arm
with CHL
d Sweden SNHL and auricular anomalies with
45,X
21 d Turkey HFSNHL was highly prevalent
10 19 Italy d
83 Sweden Age and karyotype with SNHL
47 UK d
57 UK CHL was more common in ENT
History and 45,X
39 Belgium d
49 Japan Age, karyotype, body height with
HFSNHL
34 USA Air conduction threshold was
associated with p-arm of
chromosome X
15.6 Italy CHL was associated with 45,X and
craniofacial abnormalities
6 18 Poland SNHL prevails in 45, X
9 Australia d
63 USA d
17.4 Taiwan CHL was associated with recurrent
OM
ral hearing loss; MHL Z mixed hearing loss; OM Z otitis media;
96 K.-C. Chan et al.prevails in the 45,X group,19 although others suggest a lack
of endogenous estrogens as a probable cause.21 SNHL
usually begins in the late childhood-early adulthood in
a gradually progressive manner. The audiologic pattern
often shows a symmetrical dip in the midfrequency range in
girls starting as young as 6 years of age.7 Recently, Heder-
stierna and colleagues22 reported that young and middle-
aged women with TS have a progressive SNHL, which
tends to deteriorate rapidly in the adulthood.
The incidence and characteristics of hearing loss in TS
patients have been extensively studied in Westerndbut not
in Asiandpopulations. A search in PubMed revealed only
one paper involving a case study with Asians.16 According to
the different studies published, the prevalence of hearing
loss and the otologic manifestations are variable. Moreover,
the association between auditory phenotype and karyo-
type, or other clinical variables, remains inconsistent
among TS patients. Therefore, the purpose of the present
study is to evaluate the otologic and audiologic features
among ethnic Chinese TS patients in Taiwan and to identify
probable associated causative factors for hearing loss.
Materials and methods
Patients
We recruited 46 women aged 5e34 years (average age, 17.3
years) who were referred from the pediatric endocrinology
clinic during the period from July 2009 to December 2009.
All were diagnosed as TS patients because of phenotypic
characteristics and abnormal sex chromosome karyotype,
with fewer than 30% normal cells on a 50-cell blood
karyotype. A total of 27 of the 46 patients (58.7%) had the
typical monosomy 45,X and the rest had the mosaic
karyotype (Table 2). We obtained informed consent from
each patient and the study was approved by the Medical
Ethics and the Human Clinical Trials Committee of Chang
Gung Memorial Hospital in Taoyuan, Taiwan.
Otolaryngologic and audiologic examination
A senior ear, nose, and throat specialist performed the
otolaryngologic evaluations. For each patient, we collected
information from the following sources and evaluations:Table 2 Karyotype of patients with Turner syndrome.
Karyotype Case number (%)
45,X 27 (58.7%)
45,X/46,XX 2 (4.3%)
45,X/46,XY 2 (4.3%)
45,X/46,X,i(Xq) 2 (4.3%)
45,X/46,Xþmar 3 (6.5%)
45,X/46,X,þring 4 (8.7%)
45,X/46,XdelXq 1 (2.3%)
45,X/47,XXY 1 (2.3%)
46,X,i(Xq) 2 (4.3%)
46,XdelXp 2 (4.3%)
Total 46 (100%)(a) detailed medical history, (b) otologic information,
including history of middle ear infection and past otologic
surgeries, (c) routine otoscopic examination, and (d) general
evaluation of the craniofacial anomalies, including high-
arched palate, low-set ears, micrognathia, and auricular
abnormalities.
Audiologists recorded pure tone hearing thresholds in
decibel hearing level (dB HL), detailing the air and bone
conduction in a soundproof booth. The test frequencies
were 0.125, 0.25, 0.5,1, 2, 4, and 8 kHz.
Definitions
Recurrent OM
We defined recurrent OM as more than four acute attacks of
purulent middle ear infection with symptoms such as otal-
gia and fever every year for at least 1 year.7
Hearing loss
Type, degree, and configuration of hearing loss
Our definitions for type, degree, and configuration of
hearing loss were according to the criteria of the Genetic
Deafness study group.23
The types of hearing loss were divided into conductive,
sensorineural, and mixed based on a three-frequency air
conduction pure tone average (500, 1000, and 2000 Hz). We
defined CHL as an average bone conduction threshold of
20 dB HL and an average airebone gap of 15 dB HL, and
classified hearing loss as sensorineural when the average
bone conduction threshold was >20 dB HL and the average
airebone gap was <15 dB HL. A mixed hearing loss had an
average bone conduction threshold of >20 dB HL and an
average airebone gap of 15 dB HL.
Degree of hearing loss
The degree of clinical hearing loss was based on a four-
frequency pure tone average (500, 1000, 2000, and
4000 Hz). We considered hearing thresholds 20 dB HL, >20
to 40 dB HL, >40 to 70 dB, >70 to 95 dB HL and >95 dB
HL as indicative of age-independent normal hearing, mild
hearing loss, moderate hearing loss, severe hearing loss,
and profound hearing loss, respectively.
Configuration of hearing loss
The audiometric configuration was defined as: (a) mid-
frequency U-shaped, when a difference of 15 dB HL or more
existed between the poorest thresholds in the mid-
frequencies (1e2 kHz) and those at higher- and lower-
frequencies; (b) low-frequency ascending, when there is
a difference of >15 dB HL between the poorest thresholds
and the higher frequencies; (c) flat, when mean thresholds
at 0.25 and 8 kHz differed by <15 dB HL; and (d) high-
frequency, when a difference of 15 dB HL existed between
the mean thresholds at 0.5 and 1 kHz and the mean
thresholds at 4 and 8 kHz.
Imaging
When necessary, we performed high-resolution computed
tomography (HRCT) of the temporal bone. In total, we
examined 10 patients who had CHL with adhesive OM
Figure 1 The distribution of hearing loss in pure tone audi-
ometry in Turner syndrome.
Otologic-audiologic features of Turner syndrome 97(n Z 1), chronic OM with mastoiditis (n Z 1), or SNHL
(n Z 8).
Statistical analysis
We assessed karyotypes (45, X versus mosaic), previous
recurrent OM history, and craniofacial abnormalities for
associations with hearing loss using Fisher’s exact test. A
level of p < 0.05 was considered to indicate statistical
significance; odds ratio (OR) and 95% confidence interval
(CI) were also calculated. We analyzed the data with the
SPSS package, version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
History of recurrent OM
A total of 22 patients (47.8%) had a history of recurrent OM
and five (23.8%) had been treated with myringotomy with
ventilation tubes.
Craniofacial abnormality findings
We found the following craniofacial abnormalities: high-
palate, micrognathia, lost posterior hairline, and auricular
abnormalities in 30 (65.2%), 29 (63%), 29 (63%), and 10
(21.7%) patients, respectively. The auricular abnormalities
include low-set ear (four cases), cupped auricle (three
patients), and an abnormally protruding ear (three
patients).
Otoscopic findings
A total of 21 patients (46%) had one or more abnormal
eardrum findings, including retracted eardrum (10 ears),
middle-ear effusion (two ears), adhesive ear drum (two
ears), atrophic scar (two ears), tympanoplasty graft (one
ear), and myringosclerosis (18 ears), which was the most
common. We did not detect any eardrum perforation or
cholesteatoma.
Surgical interventions
Medical histories showed that six patients (13%) had middle
ear surgery. Among them, five cases (10.9%) underwent
myringotomy with ventilation tubes for persistent middle
ear effusion. One patient (2.2%) received tympanomastoi-
dectomy for chronic OM with mastoiditis. Among the five
cases with myringotomy with ventilation tubes, two cases
had this procedure twice, and one case had the procedure
performed four times. The remaining two cases received
a ventilation tube only once.
Audiologic findings
Audiometric results (Fig. 1) showed five patients (10.7%)
with eight ears with CHL, eight patients (17.4%) with 13
ears with SNHL, and 33 patients (71.9%) with 71 ears with
normal hearing levels. There was no mixed hearing loss
diagnosed among these patients. Fig. 2 displayed theincidence of different types of hearing loss based on
numbers within the age group. However, we did not
discover an observable elevation in the incidence of CHL or
SNHL with age except in the older age group (>30 years).
Of these patients with hearing loss, mild hearing loss
(21e40 dB HL) occurred in 15 ears. Six ears had moderate
(41e70 dB HL) hearing loss, and none had severe (71e95 dB
HL) or profound (> 95 dB HL) hearing loss. Seven ears had
high-frequency hearing loss, which was the most common
configuration observed in the study. Flat configurations of
hearing loss were the second most common and were found
in five ears. The low-frequency ascending configuration of
hearing loss was presented in five ears and the mid-
frequency U-shaped pattern in four (Table 3).
Clinical associated factor analysis
Statistical analysis revealed an association between CHL
and recurrent OM (pZ 0.0192). However, karyotypes (45,X
or mosaic) and craniofacial anomalies (high-arched palate,
micrognathia, external ear abnormalities, or lower poste-
rior hair line) were not associated with CHL (p > 0.05). As
shown in Table 4, none of the clinical variables were
associated with SNHL (p > 0.05).
Imaging findings
We performed HRCT of the temporal bone in 10 selected
patients. Of the two cases with CHL, one had evidence of
chronic OM with mastoiditis before a tympanomastoidec-
tomy procedure. The other had only an adhesive tympanic
membrane without evidence of ossicular destruction or
cholesteatoma formation. None of the eight SNHL cases
showed any middle or inner ear anomaly.
Discussion
To the best of our knowledge, this is the first report on the
otologic and audiologic characteristics of Taiwanese TS
patients and only the second study to involve Asian
patients. Our results revealed an increased incidence of
recurrent OM (47.8%), abnormal otoscopic finding of
eardrum (45.6%), and varying degree of auricular anomalies
(21.7%) among TS patients. In addition, CHL was more
associated with a history of recurrent OM than SNHL,
although the later prevailed over the former (17.4% vs.
10.7%).
Figure 2 Incidence of different types of hearing loss based on number of cases (n) within age groups.
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is consistent with previous reports (Table 1).3,6,14 The
underlying causes for increased OM incidence and associ-
ated risk factors in TS patients are still controversial. It is
possible that the etiology of recurrent OM is multifactorial,
and perhaps it is related to lymphatic hypoplasia or the
aberrant anatomic shaping of the structures derived from
the first and second brachial arches.10,24
The incidence of CHL among our patients was 10.7%,
which is within the range (6%e44%) reported by others
(Table 1).4,7 These studies have found that tympanic
membrane pathology and chronic middle ear disease, from
middle ear effusion and repeated OM in the childhood,
were the principal causes for CHL in TS.4,5,7 Some reports
suggest that CHL is associated with impaired Eustachian
tube function resulted from congenital craniofacial
abnormalities.14,18
As for the correlation between variable karyotype
abnormality and CHL in TS, various authors8,14,18 haveTable 3 Profile of 13 cases (21 ears) with hearing loss.
Case Age (yr) Karyotype
Righ
1 8 45,X SNH
2 10 45,X CHL
3 12 45,X CHL
4 13 45,X SNH
5 13 45,X/46,Xþmar N
6 13 45,X/46,XdelXq SNH
7 17 45,X SNH
8 18 45,X/46,X,þring SNH
9 21 45,X SNH
10 22 45,X/46,Xþmar CHL
11 27 45,X/46,XY SNH
12 32 45,X SNH
13 34 45,X N
CHL Z conductive hearing loss; HF Z high frequency (4000e8000
(1000e2000 Hz); N Z normal; SNHL Z sensorineural hearing loss.reported that monosomy 45,X and 45X/46Xi(Xq) are
strongly associated with CHL. However, our study did not
reveal a significant correlation between CHL and monosomy
45,X or variable craniofacial anomalies. Bu contrast, we
only found that recurrent OM history was significantly
associated with CHL, which is consistent with the study by
Ostberg and others14 but not with those by Morimoto and
colleagues.16 The relative small case number in all these
studies, including ours, may explain these discrepancies
and warrants further studies with larger, more statistically
significant case numbers.
SNHL in TS patients usually begins in adolescence or
adult age and its prevalence increases with age.22 Accord-
ing to several studies, the incidence of SNHL among
different age groups in TS patients varies from 9% to 83%
(Table 1).12,20 Our study showed a relative low incidence
(17.4%, age range: 5e34 years), similar to the incidence
(19%, age range: 6e25 years) reported by Serra and
others.11 The fact that most of our patients were teenagersType/degree/configuration of hearing loss
t Left
L/moderate/HF N
/moderate/LF-ascending CHL/mild/ LF-ascending
/moderate/ LF-ascending CHL/mild/LF-ascending
L/mild/flat SNHL/mild/flat
CHL/mild/LF-ascending
L/mild/flat SNHL/mild/HF
L/mild/flat N
L/mild/flat N
L/mild/MF U-shaped SNHL/mild/MF U-shaped
/mild/HF CHL/mild/HF
L/mild/MF U-shaped SNHL/mild/MF U-shaped
L/moderate/ HF SNHL/moderate/HF
CHL/moderate/HF
Hz); LF Z low frequency (250e500 Hz); MF Z midfrequency
Table 4 Associations between clinical features and hearing loss in patients with Turner syndrome.
Clinical features (N Z 46) CHL (n Z 5) SNHL (n Z 8)
N (%) p value* OR (95% CI) N (%) p value* OR (95% CI)
Karyotype 45,X (27) Yes 3 (11.1) 1.000 1.06 (0.16e 7.06) 5 (18.5) 1.000 1.21 (0.25e 5.82)
No 2 (10.5) 3 (15.8)
Recurrent OM history (22) Yes 5 (22.7) 0.019y NA 6 (27.3) 0.128 4.12 m (0.73e23.15)
No 0 (0.0) 2 (8.3)
High-arched palate (30) Yes 5 (16.7) 0.147 NA 5 (16.7) 1.000 0.87 (0.17e4.21)
No 0 (0.0) 3 (18.8)
Micrognathia (29) Yes 4 (13.8) 0.637 2.56 (0.26e25.01) 6 (20.7) 0.691 1.96 (0.34e11.00)
No 1 (5.9) 2 (11.8)
Lower posterior hair line (29) Yes 3 (10.3) 1.000 0.86 (0.13e5.78) 7 (24.1) 0.226 5.09 (0.57e45.58)
No 2 (11.8) 1 (5.9)
Auricular abnormalityz (10) Yes 1 (10.0) 1.000 0.89 (0.09e8.97) 1 (10.0) 0.655 0.39 (0.04e3.68)
No 4 (11.1) 7 (21.9)
CHL Z conductive hearing loss; CI Z confidence interval; NA Z not available; OM Z otitis media; OR Z odds ratio;
SNHL Z sensorineural hearing loss.
* Fisher’s exact test, two-tailed.
y Statistically significant, p < 0.05.
z Low-set ear, cupped auricle and abnormally protruding ear.
Otologic-audiologic features of Turner syndrome 99(mean age 17.3 years) likely explains a lower incidence of
SNHL when compared with other studies involving young
and middle-age women.3,4,12e17,23 In addition, previous
studies have proposed that SNHL in TS patients declines
beyond what is considered a normal age-related progres-
sion.3,8,13,17 Nevertheless, our cross-sectional design did
not reveal an elevation in the incidence of SNHL with age
except in the older age group (>30 years), although the
small case number distribution among different age groups
might explain this result (Fig. 2).
Although Anderson and colleagues25 originally attributed
SNHL to a defect in the outer hair cells of the organ of
Corti, several studies have reported that TS patients do not
display inner ear malformations4,15 or cochlear abnormali-
ties.26 In line with these studies, we did not observe these
abnormalities in TS patients with SNHL. Moreover, the
results did not show a significant association between SNHL
and monosomy 45, X (Table 4). By contrast, several studies
have reported an association of SNHL with karyotype
abnormalities in TS, including the deletion of the short arm
of the X chromosome,9,12 and its prevalence in patients
with monosomy 45,X.19 Studies involving large case
numbers should help to resolve these issues.
The typical audiologic patterns of the so-called ‘Turner-
type’ SNHL are characterized by a bilateral symmetric
midfrequency dip, maximal at 2 kHz, and an average
hearing loss of 35 dB HL.4,12 Hultcrantz and others3,5 re-
ported that 50% of their TS patients had the midfrequency
sensorineural dip. Women with TS often develop this mid-
frequency depression pattern in their teens to early
adulthood, with an age of 6 years being the earliest onset
age ever reported.7 Furthermore, Hultcrantz12 also sug-
gested that the midfrequency dip correlates with karyotype
abnormality, especially 45,X or 45,X/46 Xi(Xq). In contrast
to these reports, we only observed two cases (four ears) of
MFSNHL type in the 1- to 2-kHz region. Their ages were 21
and 27 years and the karyotypes were 45,X and 45X/46,XY,respectively (Table 3). A possible reason for this discrepancy
is the different definition for MFSNHL used by the two study
groups. We defined it as a characteristic elevation of the
threshold exceeding 15 dB HL in the region of 1 to 2 kHz,
whereas Hultcrantz and colleagues3,5 defined MFSNHL as
exceeding 5 dB HL in the middle frequency (0.5e2 kHz).
Because of the relatively small sample-size of the cross-
sectional study reported here, attention must be given to
the possible confounding factors. Recall bias is one of them
in this cohort, especially the history of recurrent OM. Thus,
we would like to encourage large-scale, well-controlled,
prospective, longitudinal studies to further explore the
otologic and audiologic features in TS patients.
Conclusion
Given the inconsistencies of the previous literature based
on the otologic and audiologic features among patients with
TS, especially the inadequacy of studies performed based
on the non-Caucasian populations, we conclude from our
current study that recurrent OM is a predominant otologic
feature among the ethnic Chinese TS populations in Taiwan.
In addition, CHLdnot SNHLdis more likely to be associated
with a history of recurrent OM in the early lives of TS
patients. Hence, we recommend that all TS patients with
OM be screened with regular follow-ups and be offered
appropriate treatment starting at an early age. This could
minimize the eventual development of otologic complica-
tions as well as promoting ongoing hearing, speech, and
language development to improve patients’ ability to
function in a social setting.
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